FIELD: medicine. SUBSTANCE: method involves creation of antiviral resistance with relation to both RNA- and DNA-containing viruses. Method involves cell incubation with biologically active substance based on the DNA salt or its complex followed by separation of obtained cultural fluid from the cells. EFFECT: improved method of preparing. 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIVIRAL AGENT TO RNA- AND DNA-CONTAINING VIRUSES | 1996 |
|
RU2136286C1 |
| METHOD OF PREPARING IMMUNOTROPIC ANTIVARAL DRUG | 2000 |
|
RU2172632C1 |
| ANTIVIRAL IMMUNOTROPIC AGENT | 1999 |
|
RU2158592C1 |
| METHOD OF INACTIVATION OF AIDS VIRUS | 1992 |
|
RU2031945C1 |
| COMPOSITION SHOWING ANTI-HIV AND ANTI-HERPES ACTIVITY | 2001 |
|
RU2182828C1 |
| SUBTYPE A TYPE 1 IV710 HUMAN IMMUNODEFICIENCY VIRAL STRAIN RESISTANT TO ANTIRETROVIRAL PREPARATIONS FOR DIAGNOSTIC AND VACCINE PREPARATIONS | 2012 |
|
RU2513692C1 |
| METHOD FOR TREATMENT OF HEMOPOIESIS DISORDERS | 1993 |
|
RU2063228C1 |
| DERINAT SUPPOSITORIES TO BE USED IN MEDICAL PRACTICE | 2009 |
|
RU2429854C2 |
| HEMIN-PEPTIDE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AND USING AS ANTI-VIRAL AND VIRULICIDE AGENT | 2004 |
|
RU2296131C2 |
| METHOD FOR TREATMENT OF STOMATITIS | 1992 |
|
RU2018301C1 |
